Antithrombin Milano: A New Variant With Monomeric and Dimeric Inactive Antithrombin III

作者: M Wolf , C Boyer , A Tripodi , D Meyer , MJ Larrieu

DOI: 10.1182/BLOOD.V65.2.496.496

关键词:

摘要: A qualitative defect of antithrombin III (AT III) has been demonstrated over three generations in eight members an Italian family by the discrepancy between a normal amount antigen and decreased anti-Xa activity presence or absence heparin. By two-dimensional immunoelectrophoresis heparin, two peaks AT were present all patients9 plasma. was purified from propositus plasma sulfate dextran precipitation followed heparin affinity chromatography. The elution profile patient9s abnormal allowed separation populations III, abnormal. first fraction (normal contained activity, migrated as single peak sodium dodecyl sulfate- polyacrylamide gel electrophoresis (SDS-PAGE), band with molecular weight (mol wt) identical to that (60,000). Conversely, last fraction, devoid SDS-PAGE, bands observed: one mol wt 60,000 second 120,000. Western blots clearly cross-reactivity 120,000 monospecific antisera human III. Reduction converted it band, suggesting dimeric form name Milano is proposed for this new variant.

参考文章(15)
Robert D. Rosenberg, Paul S. Damus, The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor Journal of Biological Chemistry. ,vol. 248, pp. 6490- 6505 ,(1973) , 10.1016/S0021-9258(19)43472-8
A. Girolami, F. Fabris, G. Cappellato, L. Sainati, G. Boeri, Antithrombin III (AT III) Padua2: A “New” congenital abnormality with defective heparin co-factor activities but no thrombotic disease Annals of Hematology. ,vol. 47, pp. 93- 103 ,(1983) , 10.1007/BF02482643
K H Weisgraber, T P Bersot, R W Mahley, G Franceschini, C R Sirtori, A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. Journal of Clinical Investigation. ,vol. 66, pp. 901- 907 ,(1980) , 10.1172/JCI109957
P.J. Sørensen, G. Sas, I. Petó, Gy. Blaskó, T. Kremmer, A. Samu, Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'. Thrombosis Research. ,vol. 26, pp. 211- 219 ,(1982) , 10.1016/0049-3848(82)90142-6
Takehiko Koide, Kaoru Takahashi, Shoji Odani, Teruo Ono, Nobuo Sakuragawa, Isolation and characterization of a hereditary abnormal antithrombin III 'Antithrombin III Toyama'. Thrombosis Research. ,vol. 31, pp. 319- 328 ,(1983) , 10.1016/0049-3848(83)90334-1
Pamela J. Fraker, John C. Speck, Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril Biochemical and Biophysical Research Communications. ,vol. 80, pp. 849- 857 ,(1978) , 10.1016/0006-291X(78)91322-0
M. Wolf, C. Boyer, J. M. Lavergne, M. J. Larrieu, A new familial variant of antithrombin III: 'antithrombin III Paris'. British Journal of Haematology. ,vol. 51, pp. 285- 295 ,(1982) , 10.1111/J.1365-2141.1982.TB02782.X
Antonio Girolami, Michele Rubetelli, Franco Marafiotti, Adriana Zamboni, Maria Angela Vicarioto, CROSSED IMMUNOELECTROPHORESIS IN THE STUDY OF ABNORMAL ANTITHROMBINS III: BEHAVIOUR OF AT III TRENTO British Journal of Haematology. ,vol. 55, pp. 559- 561 ,(1983) , 10.1111/J.1365-2141.1983.TB02173.X